Farallon Capital Management’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Farallon Capital Management’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-134,175	Closed	-$1.91M	–	328
2021 Q2	$1.91M	Hold	134,175	–	–	0.01%	211
2021 Q1	$566K	Hold	134,175	–	–	﹤0.01%	233
2020 Q4	$758K	Buy	+134,175	New	+$541K	﹤0.01%	136

Farallon Capital Management's CEREW Position: Q3 2021 in Review

Farallon Capital Management sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 134,175 shares — an estimated $1.91M sold.

Farallon Capital Management first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $1.91M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Farallon Capital Management reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Farallon Capital Management sold 134,175 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $1.91M.
Farallon Capital Management first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
Farallon Capital Management's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $1.91M in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.